ES2661081T3 - Reactivo de liberación para compuestos de vitamina D - Google Patents

Reactivo de liberación para compuestos de vitamina D Download PDF

Info

Publication number
ES2661081T3
ES2661081T3 ES11720110.3T ES11720110T ES2661081T3 ES 2661081 T3 ES2661081 T3 ES 2661081T3 ES 11720110 T ES11720110 T ES 11720110T ES 2661081 T3 ES2661081 T3 ES 2661081T3
Authority
ES
Spain
Prior art keywords
vitamin
releasing
compounds
release reagent
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11720110.3T
Other languages
English (en)
Inventor
Sascha Antoni
Christian Vogl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2661081T3 publication Critical patent/ES2661081T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/203332—Hydroxyl containing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un procedimiento in vitro para liberar un compuesto de vitamina D desde la proteína de unión a la vitamina D que comprende la etapa de: a) proporcionar una muestra que se va a investigar y b) mezclar la muestra de la etapa (a) con i) un reactivo que contiene una sal de hidrogenocarbonato en una concentración de 0,1 M a 2,0 M o una sustancia capaz de liberar iones hidrogenocarbonato (HCO3) tras hidrólisis en una concentración de 0,1 M a 2,0 M, ii) un agente reductor, y iii) un agente alcalinizante, liberando de este modo el compuesto de vitamina D desde la proteína de unión a la vitamina D.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17

Claims (1)

  1. imagen1
    imagen2
ES11720110.3T 2010-05-20 2011-05-18 Reactivo de liberación para compuestos de vitamina D Active ES2661081T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10163453 2010-05-20
EP10163453 2010-05-20
EP11158296 2011-03-15
EP11158296 2011-03-15
PCT/EP2011/058048 WO2011144661A1 (en) 2010-05-20 2011-05-18 Release reagent for vitamin d compounds

Publications (1)

Publication Number Publication Date
ES2661081T3 true ES2661081T3 (es) 2018-03-27

Family

ID=44148660

Family Applications (2)

Application Number Title Priority Date Filing Date
ES17202244T Active ES2795849T3 (es) 2010-05-20 2011-05-18 Reactivo de liberación para compuestos de vitamina D
ES11720110.3T Active ES2661081T3 (es) 2010-05-20 2011-05-18 Reactivo de liberación para compuestos de vitamina D

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES17202244T Active ES2795849T3 (es) 2010-05-20 2011-05-18 Reactivo de liberación para compuestos de vitamina D

Country Status (12)

Country Link
US (4) US20130078729A1 (es)
EP (2) EP2572204B1 (es)
JP (1) JP5711811B2 (es)
KR (1) KR101494952B1 (es)
CN (1) CN102906570B (es)
AU (1) AU2011254567B2 (es)
BR (1) BR112012027147B1 (es)
CA (1) CA2796576C (es)
ES (2) ES2795849T3 (es)
PL (1) PL2572204T3 (es)
SG (1) SG185456A1 (es)
WO (1) WO2011144661A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2572204B1 (en) 2010-05-20 2017-12-27 Roche Diagnostics GmbH Release reagent for vitamin d compounds
WO2014179737A2 (en) 2013-05-03 2014-11-06 The General Hospital Corporation Assays and methods of treatment relating to vitamin d insufficiency
JP5918784B2 (ja) * 2011-01-07 2016-05-18 ザ ジェネラル ホスピタル コーポレイション ビタミンｄ欠乏症に関連するアッセイおよび治療方法
US9052308B2 (en) 2011-01-07 2015-06-09 The General Hospital Corporation Assays and methods of treatment relating to vitamin D insufficiency
EP3467510B1 (en) 2011-11-18 2022-10-26 F. Hoffmann-La Roche AG Release reagent for vitamin d compounds
CN103163306B (zh) * 2013-02-05 2015-06-17 北京九强生物技术股份有限公司 25羟维生素d检测试剂盒及其制备方法
WO2014122974A1 (ja) * 2013-02-06 2014-08-14 富士レビオ株式会社 カオトロピック剤を利用するビタミンｄの測定方法
DE102013205055A1 (de) * 2013-03-21 2014-09-25 Orgentec Diagnostika Gmbh Verfahren und Reagenz zur Bestimmung von Vitamin D Metaboliten
WO2015005754A1 (ko) * 2013-07-12 2015-01-15 삼성전자 주식회사 뷰 합성 예측을 이용한 인터 레이어 비디오 복호화 방법 및 그 장치 뷰 합성 예측을 이용한 인터 레이어 비디오 부호화 방법 및 장치
CN104076155B (zh) * 2014-07-10 2016-08-31 深圳市新产业生物医学工程股份有限公司 用于检测25-羟基维生素d的检测剂及制备方法和应用
US10114030B2 (en) 2014-07-10 2018-10-30 Shenzhen New Industries Biomedical Engineering Co., Ltd Detection agent for detecting 25-hydroxy vitamin D, preparation method and use
KR102425339B1 (ko) * 2014-12-08 2022-07-25 에프. 호프만-라 로슈 아게 비타민 d 의 측정을 위한 방법
DE102016109017B4 (de) * 2016-05-17 2018-06-14 Wincor Nixdorf International Gmbh Kistenstapelsystem und Kistenstapelvorrichtung
CN106199015B (zh) * 2016-06-27 2018-08-17 江苏拜明生物技术有限公司 用于血清样品检测的维生素d释放剂、制备方法及应用
WO2018178068A1 (en) * 2017-03-28 2018-10-04 Roche Diagnostics Gmbh Generic pretreatment reagents for analyte determinations
KR102108966B1 (ko) 2017-10-31 2020-05-12 (주)울텍 원자층 증착 시스템
CN108089015B (zh) * 2017-12-18 2020-07-24 郑州安图生物工程股份有限公司 用于检测人血清样品中25羟基维生素d含量的释放剂及其检测方法
CN110749664A (zh) * 2019-08-29 2020-02-04 重庆同怡生物技术研究院有限公司 一种25-羟基维生素d结合蛋白的解离方法
CN113884687B (zh) * 2021-12-08 2022-02-11 南京岚轩生物科技有限公司 用于检测25-羟基维生素d含量的解离剂及其制备方法
CN114011111B (zh) * 2022-01-05 2022-04-01 广州科方生物技术股份有限公司 用于结合蛋白中萃取维生素的萃取液及其制备方法和应用
CN115774112B (zh) * 2023-02-10 2023-05-12 可孚医疗科技股份有限公司 一种25-羟基维生素d解离液、检测方法、应用及试剂盒
CN119827779A (zh) * 2023-10-12 2025-04-15 菲鹏生物股份有限公司 维生素d均相检测方法和试剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5710085B2 (es) 1973-05-04 1982-02-24
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0376042B1 (en) 1988-12-27 1996-03-13 GRUPPO LEPETIT S.p.A. Improved chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
JPH06109727A (ja) 1992-08-14 1994-04-22 Wisconsin Alumni Res Found １，２５−ジヒドロキシビタミンｄの検定法
ATE191712T1 (de) 1993-07-09 2000-04-15 Theramex Neue strukturelle vitamin d derivate
US5714586A (en) 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US5821020A (en) 1995-07-14 1998-10-13 Nhh Biologics Vitamin D assay
CA2239617A1 (en) 1995-12-29 1997-07-10 A And D Assay, Incorporated Labeled vitamin d compounds and the use thereof
AU763458B2 (en) 1998-06-25 2003-07-24 Biomedica Gmbh Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1alpha,25-dihydroxy-vitamin D
JP2002107350A (ja) 2000-10-03 2002-04-10 Nippon Zoki Pharmaceut Co Ltd ５−ヒドロキシクレアチニンの測定法
GB0029729D0 (en) * 2000-12-06 2001-01-17 Ids Ltd Method for detection of vitamin D metabolites
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
WO2003023394A2 (en) 2001-09-12 2003-03-20 Phares Pharmaceutical Research N.V. Kit for screening compounds with low water solubility
DE10144905C2 (de) 2001-09-12 2003-07-31 Immundiagnostik Ag Bestimmung von Vitamin-D direkt in Serum oder Plasma
EP1512017B1 (en) 2002-06-10 2013-05-29 Scimed Laboratories Inc. Extraction and quantification of vitamins a & d in fluid samples
US20040054160A1 (en) 2002-09-16 2004-03-18 Santona Pal Nucleic-acid ink compositions for arraying onto a solid support
US20040132104A1 (en) 2003-01-07 2004-07-08 Sackrison James L. Vitamin D assay
CN101273272B (zh) * 2005-09-29 2012-11-07 霍夫曼-拉罗奇有限公司 维生素d化合物的释放试剂
ATE452343T1 (de) * 2006-06-06 2010-01-15 Hoffmann La Roche Verbesserte vitamin-d-messung
ATE472734T1 (de) 2007-02-01 2010-07-15 Immundiagnostik Ag Direktbestimmung von vitamin d im serum oder plasma
JP5177630B2 (ja) * 2007-09-28 2013-04-03 独立行政法人産業技術総合研究所 Ｈｃｖ患者における瀉血治療の効果の検査方法
EP2572204B1 (en) 2010-05-20 2017-12-27 Roche Diagnostics GmbH Release reagent for vitamin d compounds

Also Published As

Publication number Publication date
EP3327442B1 (en) 2020-04-01
CN102906570B (zh) 2014-11-05
HK1176406A1 (en) 2013-07-26
JP2013529304A (ja) 2013-07-18
EP2572204B1 (en) 2017-12-27
JP5711811B2 (ja) 2015-05-07
US20160356795A1 (en) 2016-12-08
US20130078729A1 (en) 2013-03-28
CN102906570A (zh) 2013-01-30
WO2011144661A1 (en) 2011-11-24
AU2011254567B2 (en) 2014-04-10
KR101494952B1 (ko) 2015-02-23
BR112012027147A2 (pt) 2016-08-02
PL2572204T3 (pl) 2018-05-30
US20150226753A1 (en) 2015-08-13
SG185456A1 (en) 2012-12-28
US20150024506A1 (en) 2015-01-22
CA2796576A1 (en) 2011-11-24
AU2011254567A1 (en) 2012-11-01
EP2572204A1 (en) 2013-03-27
CA2796576C (en) 2015-06-23
EP3327442A1 (en) 2018-05-30
ES2795849T3 (es) 2020-11-25
BR112012027147B1 (pt) 2020-02-27
US10451639B2 (en) 2019-10-22
KR20130020793A (ko) 2013-02-28

Similar Documents

Publication Publication Date Title
ES2528970T3 (es) Métodos de producción de microesferas de amplificación de señal
ES2542780T3 (es) Agente acelerante para curar resinas
BRPI0911067B8 (pt) métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido
CL2010001651A1 (es) Proceso para la obtencion de compuestos de cobre nanoparticulados de superficie modificada que comprende mezclar dos soluciones, una que contiene iones de cobre y otra que contiene al menos un anion, en donde al menos una de ellas contiene un polimero soluble en agua; compuestos de cobre y su uso; y proceso para preparar dispersiones acuosas.
CL2009000854A1 (es) Proceso y aparato para tratar una solucion acuosa que contiene un contaminante quimico que comprende poner en contacto la solucion acuosa que contiene un contaminante quimico con una composicion que contiene un compuesto insoluble que comprende tierras raras; y dispositivo.
ES2616049T3 (es) Mejora de la función renal con composiciones que contienen quercetina
CA2796576A1 (en) Release reagent for vitamin d compounds
ES2532265T3 (es) Mezcla aceleradora y método de uso
EP3955004A3 (en) Use of fatty acids in methods for detecting cancer
BR112013018352A2 (pt) composição de minociclina tópica e método
CL2012003625A1 (es) Una composicion acuosa que contiene bromhexina, en donde la composicion tiene una cantidad de azucar-alcoholes inferior a 10 g referida a 100 ml de la composicion; y su uso para la terapia secretorica en enfermedades broncopulmonares agudas y cronicas.
BR112013003460A2 (pt) revestimento óptico compreendendo nanopartículas de sílica porosas
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
CL2013000163A1 (es) Proceso para la preparacion de material de carbonato de calcio que comprende proveer al menos un material que contenga carbonato de calcio, proveer al menos una sal de un acido graso c5-c28, tratar el material poniendolo en contacto con dicho acido graso y obtener dicho material tratado superficialmente; material de carbonato de calcio; y su uso en el control de material organico en un medio acuoso.
BRPI0720361A8 (pt) Método para medir aglutinação de uma ou mais partículas em um ensaio de aglutinação induzida por alvo efetuado em uma câmara de reação, e, kit e dispositivo para medir um ou mais parâmetros de aglutinação de partículas em um ensaio de aglutinação induzida por alvo
CL2012000374A1 (es) Metodo para la preparacion de una composicion saborizante activa que comprende una primera reaccion entre un compuesto amino y un carbonilo, resultando una primera mezcla de intermediarios, una segunda reaccion con un segundo compuesto amino solo o en combinacion con un compuesto carbinilo, resultando una segunda mezcla de intermediarios, reacciones serparadas adicionales con compuestos de otras clases quimicas, ultima reaccion que comprende una mezcla de todas las mezclas de intermediarios anteriores.
BR112012018115A2 (pt) dispositivo, sistema, e, método
ECSP11010762A (es) Composición tópica para el tratamiento de queratosis actínica
BR112015006273A2 (pt) ''método de prognóstico, kit que compreende reagentes, agente quimioterápico citotóxico terapêutico, uso de um agente quimioterápico citotóxico terapêutico, sistema para prognóstico de sobrevivência global e meio legível por computador''
BRPI0912229A2 (pt) mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
AR079704A1 (es) Anticuerpos anti-bv8 y sus usos
MX2015013310A (es) Metodo y reactivo para determinar metabolitos de la vitamina d.
AR070772A1 (es) Metodo de voladura adicionalmente mejorado
DOP2009000089A (es) Inhibidores de cinasa mapk/erk
ES2508165T3 (es) Lactoferrina y sustancia blanca